Active comparator trial of teriparatide versus alendronate in the treatment of glucocorticoid-induced osteoporosis

被引：0
|
作者：
Saag, K. G. [1 ]
Shane, E. [2 ]
Boonen, S. [3 ]
Donley, D. W. [4 ]
Marin, F. [4 ]
Warner, M. R. [4 ]
Taylor, K. A. [4 ]
Dalsky, G. R. [4 ]
Marcus, R. [4 ]
机构：
[1] Univ Alabama, Birmingham, AL USA
[2] Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA
[3] Katholieke Univ Leuven, Div Geriatr Med, Louvain, Belgium
[4] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：117 / 117
页数：1
相关论文
共 50 条
  • [21] EXPERIENCE ON THE USE OF TERIPARATIDE FOR TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS
    Saparbayeva, M.
    Issayeva, B.
    Issayeva, S.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S377 - S378
  • [22] Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis
    de Nijs, Ron N. J.
    Jacobs, Johannes W. G.
    Lems, Willem F.
    Laan, Roland F. J.
    Algra, Ale
    Huisman, Anne-Margriet
    Buskens, Erik
    de laet, Chris E. D.
    Oostveen, Ans C. M.
    Geusens, Piet P. M. M.
    Bruyn, George A. W.
    Dijkmans, Ben A. C.
    Bijlsma, Johannes W. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (07): : 675 - 684
  • [23] Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis
    Minisola, Salvatore
    Scillitani, Alfredo
    Romagnoli, Elisabetta
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (20): : 2156 - 2157
  • [24] Teriparatide versus alendronate in glucocorticoid-induced osteoporosis: Results of a subgroup analysis in men, pre- and postmenopausal women
    Langdahl, B.
    Dobnig, H.
    Zanchetta, J. R.
    Maricic, M.
    Krohn, K.
    See, K.
    Marin, F.
    Warner, M. R.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S251 - S251
  • [25] Effects of denosumab versus teriparatide in glucocorticoid-induced osteoporosis patients with prior bisphosphonate treatment
    Hirooka, Yasuaki
    Nozaki, Yuji
    Inoue, Asuka
    Li, Jinhai
    Shiga, Toshihiko
    Kishimoto, Kazuya
    Sugiyama, Masafumi
    Kinoshita, Koji
    Funauchi, Masanori
    Matsumura, Itaru
    BONE REPORTS, 2020, 13
  • [26] The efficiency and safety of alendronate versus teriparatide for treatment glucocorticoid-induced osteoporosis: A meta-analysis and systematic review of randomized controlled trials
    Liu, Zhi-Ming
    Zhang, Min
    Zong, Yuan
    Zhang, Ding
    Shen, Zhu-Bin
    Guan, Xiao-Qing
    Yin, Fei
    PLOS ONE, 2022, 17 (05):
  • [27] Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis - Reply
    de Nijs, Ron N. J.
    Jacobs, Johannes W. G.
    Bijlsma, Johannes W. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (20): : 2157 - 2157
  • [28] Baseline Glucocorticoid Dose and Bone Mineral Density Response with Teriparatide or Alendronate Therapy in Patients with Glucocorticoid-induced Osteoporosis
    Devogelaer, Jean-Pierre
    Adler, Robert A.
    Recknor, Chris
    See, Kyoungah
    Warner, Margaret R.
    Wong, Mayme
    Krohn, Kelly
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (01) : 141 - 148
  • [29] Effects of Teriparatide Versus Alendronate for Treating Glucocorticoid-Induced Osteoporosis Thirty-Six-Month Results of a Randomized, Double-Blind, Controlled Trial
    Saag, Kenneth G.
    Zanchetta, Jose R.
    Devogelaer, Jean-Pierre
    Adler, Robert A.
    Eastell, Richard
    See, Kyoungah
    Krege, John H.
    Krohn, Kelly
    Warner, Margaret R.
    ARTHRITIS AND RHEUMATISM, 2009, 60 (11): : 3346 - 3355
  • [30] A Meta-analysis of alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis
    杨琳
    ChinaMedicalAbstracts(InternalMedicine), 2013, 30 (04) : 207 - 208
12345